Overexpression of bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis

International Journal of Cancer

Volumn 67, Issue 1, 1996, Pages 101-105

  Sakakura, Chouhei ^a,b   Sweeney, Elizabeth A ^b   Shirahama, Tsutomu ^b   Igarashi, Yasuyuki ^b   Hakomori, Sen Itiroh ^b   Nakatani, Hirohisa ^a   Tsujimoto, Hiroyuki ^a   Imanishi, Tsutomu ^a   Ohgaki, Masaharu ^a   Ohyama, Takakuki ^a   Yamazaki, Junya ^a   Hagiwara, Akeo ^a   Yamaguchi, Toshiharu ^a   Sawai, Kiyoshi ^a   Takahashi, Toshio ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b The Biomembrane Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER RESISTANCE; CONTROLLED STUDY; EXPRESSION VECTOR; HUMAN; HUMAN CELL; IONIZING RADIATION; PRIORITY JOURNAL; RADIOSENSITIVITY;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BREAST NEOPLASMS; DNA DAMAGE; FEMALE; FLOW CYTOMETRY; HUMANS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIATION TOLERANCE; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 8944244998     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960703)67:1<101::AID-IJC17>3.0.CO;2-H     Document Type: Article

References (26)

1. BARGOUR.C., DANIEL, P.T., MAPARA, M.Y., BOMMERT, K., WAGENER, C, KALLINICH, B., ROYER, H.D. and DOERKEN, B., Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax-α expression in tumor cells correlates with resistance towards apoptosis. Int. J. Cancer, 60, 854-859 (1995).
2. BRACHMAND.G., BECKETT, M., GRAVES, D., HARAF, D., YOKES, E. and WEICHSELBAUM, R.R., p53 mutation does not correlate with radiosensitivity in head and neck cancer cell lines. Cancer Res., 53, 3666-3669 (1993).
3. CHENM., QUINTANS, J., FUKS, Z., THOMPSON, C., KUFE, D.W. and WEICHSELBAUM, R.R., Suppression of bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factorn α, and ceramide. Cancer Res., 55, 991-994 (1995).
4. CHIOUS.K., RAO, L. and WHITE, E., Bcl-2 blocks p53 dependent apoptosis. Mol. cell. Biol., 14, 2556-2563 (1994).
5. CLARKEA.R., PURDIE, C.A., HARRISON, D.J., MORRIS, R.G., BIRD, C.C., HOOPPER, M.L. and WYLLIE, A.H., p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (Lond.), 362, 847-849 (1994).
6. DOLEM., NUÑEZ, G., MERCHANT, A.K., MAYBAUM, J., RODE, C.K., BLOCK, C.A. and CASTLE, V.P., Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res., 54, 3253-3259 (1994).
7. L is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis. Cancer Res., 55, 2576-2582 (1995).
8. EL-DEIRYW.S., TORINO, T., VELCULESCU, V.E., LEVY, D.B., PARSONS, R., TRENT, J.M., LIN, D., MERCER, W.E., KINZLER, K.W. and VOGELSTEIN, B., WAF1, a potential mediator of p53 tumor suppression. Cell, 75, 817-825 (1993).
9. FANS., EL-DEIRY, W.S., BAE, I., FREEMAN, J., JONDLE, D., BHATIA, K., FORNACE, A.J., JR., MAGRATH, I., KOHN, K.W. and O'CoNNOR, P.M., p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res., 54, 5824-5830 (1994).
10. GEEJ.M.W., ROBERTSON, J.F.R., ELLIS, I.O., WILLSHER, P., MCCLELLAND, R.A., HOYLE, H.B., KYME, S.R., FINLAY, P., BLAMEY, R.W. and NICHOLSON, R.I., Immunocytochemical localization of bcl-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy. Int. J. Cancer, 59, 619-628 (1994).
11. 1 cyclin-dependent kinases. Cell, 75, 805-816 (1993).
12. KAMESAKIS., KAMESAKI, H., JORGENSEN, T.J., TANIZAWA, A., POMMIER, Y. and COSSMAN, J., bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair. Cancer Res., 53, 4251-4256 (1993).
13. KORSMERYERS.J., bcl-2: an antidote to programmed cell death. Cancer Surv., 15, 105-118 (1992).
14. LEEKR.D., KAKLAMANIS, L., PEZZELLA, F., GATTER, K.C. and HARRIS, A.L., Bcl-2 in normal breast and carcinoma, associated with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer. Brit. J. Cancer, 69, 135-139 (1994).
15. LOWES.W., RULEY, H.E., JACKS, T. and HOUSMAN, D.E., p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74, 957-967 (1993).
16. NIWAH., YAMAMURA, K. and MIYAZAKI, J., Efficient selection for high-expression transfectant with a novel eukaryotic vector. Gene, 108, 193-200 (1991).
17. NUNEZG. and CLARKEM.F., The bcl-2 family of proteins: regulators of cell death and survival. Trends Cell Biol., 4, 399-403 (1994).
18. OHTAH., SWEENEY, E.A., MASAMUNE, A., YATOMI, Y., HAKOMORI, S. and IGARASHI, Y., Induction of apoptosis by sphingosine in human leukemia HL-60 cells: a possible endogenous modulator of apoptotic DNA fragmentation occurring during phorbol ester-induced differentiation. Cancer Res., 55, 691-697 (1995).
19. OLTVAIZ.N., MILLIMAN, C.L. and KORSMEYER, S.J., Bcl-2 heterodimerize in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell, 74, 609-619 (1993).
20. SAKAKURAC, YAMAGUCHI-IWAIY., SATAKE, M., BAE, S.C., TAKAHASHI, A., OGAWA, E., HAGIWARA, A., TAKAHASHI, T., MURAKAMI, A., MAKING, K., NAKAGAWA, T., KAMADA, N. and ITO, Y., Growth inhibition and induction of differentiation of t(8;21) acute myeloid leukemia cells by the DNA-binding domain of PEBP2 and the AML/MTG8(ETO)-specific antisense oligonucleotide. Proc. nat. Acad. Sci. (Wash.), 91, 11723-11727 (1994).
21. SILVESTRINIR., VENERONI, S., DAIDONE, M.G., BENINI, E., BORACCHI, P., MEZZETTI, M., DIFRONZO, G., RILKE, F. and VERONESI, U., The bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer in patients. J. nat. Cancer Inst., 86, 499-504 (1994).
22. 1 checkpoint does not decrease cell survival following DNA damage. Cancer Res., 53, 4164-4168 (1993).
23. SUMANTRANV.N., EALOVEGA, M.W., NUÑEZ, G., CLARKE, M.F. and WICHA, M.S., Overexpression of bcl-Xs sensitizes MCF-7 cells to chemotherapy-induced apoptosis. Cancer Res., 55, 2507-2510 (1995).
24. TSUJIMOTOY., COSSMAN, J., JAPPE, E. and CROCE, C.M., Involvement of the bcl-2 oncogene in human follicular lymphoma. Science, 228, 1440-1443 (1985).
25. WAGAS., HANNON, G.J., BEACH, D. and STILLMAN, B., The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature (Lond.), 369, 574-578 (1994).
26. ZHANQ., FAN, S., BAE, I., GUILLOUF, C., LIEBERMANN, D.A., O'CONNOR, P.M. and FORNACE, A.J. JR., Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene, 9, 3743-3751 (1994).